Matthew T. DiMare

Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

Sabrina Baltschukat, Barbara Schacher Engstler, Alan Huang et al. · Clinical Cancer Research · 2019 · 171 citations

A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity

Daniel A. Bachovchin, Luke W. Koblan, Wengen Wu et al. · Nature Chemical Biology · 2014 · 74 citations · Full text

Dipeptide Boronic Acid Inhibitors of Dipeptidyl Peptidase IV: Determinants of Potency and in Vivo Efficacy and Safety

Beth A. Connolly, David G. Sanford, Amrita K. Chiluwal et al. · Journal of Medicinal Chemistry · 2008 · 70 citations · Full text

Medicinal Chemistry, Dipeptide Boronic Acids, Pharmaceutical Science +15

Human FGF-21 Is a Substrate of Fibroblast Activation Protein

Andrew L. Coppage, Kathryn R. Heard, Matthew T. DiMare et al. · PLoS ONE · 2016 · 68 citations · Full text

Fap Cleavage Site, Human Fgf-21, Metabolic Remodeling +18

Degron mediated BRM/SMARCA2 depletion uncovers novel combination partners for treatment of BRG1/SMARCA4-mutant cancers

Florencia Rago, Matthew T. DiMare, GiNell Elliott et al. · Biochemical and Biophysical Research Communications · 2018 · 36 citations

Tumor Biology, Brg1/smarca4-mutant Cancers, Medicine +11